Lilly Just Placed Million Bet on Injectables Boom
Lilly is backing Absci with a $40 million investment as Absci advances ABS-201, a next-gen injectable targeting hair ...
We compare value-focused dividend growth ETFs to help you spot the best option based on cost, yield, and growth potential.
27,266 articlesLilly is backing Absci with a $40 million investment as Absci advances ABS-201, a next-gen injectable targeting hair ...
Alibaba is emerging as a potential sleeper AI winner in 2026, trading at a discount while advancing open-source AI an...
XRP on-chain activity climbs to a fresh milestone as big holders stock up, even as the price slips under $1.45. The m...
A billionaire-backed fund is quietly accumulating Robinhood stock even as executives unload shares, a move prompting ...
Investors and policymakers are debating the impact of politicians’ stock holdings as volatility grips markets. Expert...
Public disputes can hit more than pride—they touch brand value and bank balances. Learn how chris brown avoids “inter...
As biotech earnings season unfolds, Precigen (PGEN) 2025 earnings take center stage. This guide breaks down what to m...
A high-profile public exchange ended with an apology that reveals valuable money-saving lessons for fans, creators, a...
Investors are weighing XRP and Dogecoin as potential additions to a volatile portfolio. This guide breaks down risk, ...
LBank will stage a VIP Matchday around the Argentina vs Austria World Cup 2026 clash at AT&T Stadium in Dallas, spotl...
A major shakeup in AI deals spotlights coding as a premier use case for generative AI. Google hires Windsurf talent a...
NVIDIA and Palantir are teaming up to push AI into the most secure government environments. This article breaks down ...